BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 3722363)

  • 1. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus.
    Clements ML; Betts RF; Tierney EL; Murphy BR
    J Clin Microbiol; 1986 Jul; 24(1):157-60. PubMed ID: 3722363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.
    Clements ML; Murphy BR
    J Clin Microbiol; 1986 Jan; 23(1):66-72. PubMed ID: 3700610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines.
    Powers DC; Sears SD; Murphy BR; Thumar B; Clements ML
    J Clin Microbiol; 1989 Dec; 27(12):2666-71. PubMed ID: 2592535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine.
    Johnson PR; Feldman S; Thompson JM; Mahoney JD; Wright PF
    J Med Virol; 1985 Dec; 17(4):325-35. PubMed ID: 4078559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live Victoria/75-ts-1[E] influenza A virus vaccines in adult volunteers: role of hemagglutinin immunity in protection against illness and infection caused by influenza A virus.
    Douglas RG; Markoff LJ; Murphy BR; Chanock RM; Betts RF; Hayden FG; Levine MM; Van Blerk GA; Sotman SB; Nalin DR
    Infect Immun; 1979 Oct; 26(1):274-9. PubMed ID: 500204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum.
    Wagner DK; Clements ML; Reimer CB; Snyder M; Nelson DL; Murphy BR
    J Clin Microbiol; 1987 Mar; 25(3):559-62. PubMed ID: 3571460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.
    Gorse GJ; Belshe RB; Munn NJ
    J Clin Microbiol; 1986 Sep; 24(3):336-42. PubMed ID: 3531226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies.
    Powers DC; Murphy BR; Fries LF; Adler WH; Clements ML
    J Am Geriatr Soc; 1992 Feb; 40(2):163-7. PubMed ID: 1740601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine.
    Johnson PR; Feldman S; Thompson JM; Mahoney JD; Wright PF
    J Infect Dis; 1986 Jul; 154(1):121-7. PubMed ID: 3711685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.
    Clements ML; O'Donnell S; Levine MM; Chanock RM; Murphy BR
    Infect Immun; 1983 Jun; 40(3):1044-51. PubMed ID: 6852910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory.
    Powers DC; Fries LF; Murphy BR; Thumar B; Clements ML
    J Clin Microbiol; 1991 Mar; 29(3):498-505. PubMed ID: 2037667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemagglutinin-specific antibody responses in immunoglobulin G, A, and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus.
    Burlington DB; Clements ML; Meiklejohn G; Phelan M; Murphy BR
    Infect Immun; 1983 Aug; 41(2):540-5. PubMed ID: 6874068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses.
    Murphy BR; Phelan MA; Nelson DL; Yarchoan R; Tierney EL; Alling DW; Chanock RM
    J Clin Microbiol; 1981 Mar; 13(3):554-60. PubMed ID: 7240388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory.
    Wright PF; Murphy BR; Kervina M; Lawrence EM; Phelan MA; Karzon DT
    Infect Immun; 1983 Jun; 40(3):1092-5. PubMed ID: 6852914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunogenic activity of the viral hemagglutinin and neuraminidase from live and inactivated influenza vaccines].
    Kustikova IuG; Gagarinova VM; Gorev NE; Shadrin AS
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):79-84. PubMed ID: 6868890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines.
    Gorse GJ; Belshe RB; Munn NJ
    J Clin Microbiol; 1988 May; 26(5):911-8. PubMed ID: 3384914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
    Belshe RB; Gruber WC; Mendelman PM; Mehta HB; Mahmood K; Reisinger K; Treanor J; Zangwill K; Hayden FG; Bernstein DI; Kotloff K; King J; Piedra PA; Block SL; Yan L; Wolff M
    J Infect Dis; 2000 Mar; 181(3):1133-7. PubMed ID: 10720541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.